About
Founded by Leon Recanati in 2003, the GlenRock Group leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns. With a global presence and ready access to the most prominent names in Israeli business, academia, and science, GlenRock is experienced at identifying Life Sciences and advanced technology opportunities - and leading them to realization of their true market potential. GlenRock takes an active and long-term role in the development and growth of portfolio companies ensuring that extraordinary ideas evolve into business success stories.
Key facts
- Website
- grg.co.il
- Type
- Private Equity
- Headquarters
- Israel
- Portfolio companies
- 39
- Stages
- Private EquitySeedSeries ASeries BSeries D
- Cheque size
- $1M to $35M
- Sector focus
- Computational BiologyLife SciencesMicrobiomeHealthcareDrug Development
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 19 Sept 2025 | 537340 | Undisclosed round | Undisclosed |
| 12 May 2025 | Classiq | Series C | $110M |
| 26 Feb 2025 | 249179 | Seed | $23M |
| 25 Feb 2025 | Quantum Machines | Series C | $170M |
| 25 Jul 2024 | Scopio Labs | Series D | $42M |
| 24 Jul 2024 | Scopio Labs | Undisclosed round | $10M |
| 16 Jul 2024 | Nurami Medical | Grant | $3M |
| 18 Apr 2024 | MagnusMetal | Series B | $74M |
| 12 Mar 2024 | 407961 | Seed | Undisclosed |
| 13 Nov 2023 | 472255 | Undisclosed round | $18M |
Frequently asked
What companies has GlenRock Israel invested in?
GlenRock Israel has invested in 537340, Classiq, 249179, Quantum Machines, Scopio Labs and 34 more.

